TAHOR for Dyslipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where TAHOR was used for Dyslipidaemia.
Most Reported Side Effects for TAHOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatocellular injury | 11 | 8.9% | 0 | 8 |
| Rhabdomyolysis | 11 | 8.9% | 2 | 10 |
| Cholestasis | 9 | 7.3% | 0 | 5 |
| Renal failure | 8 | 6.5% | 1 | 7 |
| Thrombocytopenia | 8 | 6.5% | 4 | 6 |
| Drug reaction with eosinophilia and systemic symptoms | 6 | 4.8% | 0 | 6 |
| Inflammation | 6 | 4.8% | 0 | 3 |
| Lung disorder | 6 | 4.8% | 3 | 6 |
| Pancytopenia | 6 | 4.8% | 0 | 6 |
| Weight decreased | 6 | 4.8% | 0 | 1 |
| Abdominal pain upper | 5 | 4.0% | 0 | 4 |
| Diarrhoea | 5 | 4.0% | 0 | 1 |
| Interstitial lung disease | 5 | 4.0% | 2 | 4 |
Other Indications for TAHOR
Other Drugs Used for Dyslipidaemia
ATORVASTATIN (4,796)
ROSUVASTATIN (2,032)
SIMVASTATIN (1,253)
EVOLOCUMAB (1,056)
EZETIMIBE (787)
PRAVASTATIN (747)
FENOFIBRATE (606)
EZETIMIBE\SIMVASTATIN (302)
ATORVASTATIN\EZETIMIBE (239)
DEVICE (172)